COMP <GO>
BOLD vs XBIT // ENTERPRISE SCALE & MARKET CAP
Boundless Bio Inc. (NASDAQ) VS. XBiotech Inc. (NASDAQ) • 15-METRIC TALLY: BOLD 2
— XBIT 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: XBIT
LAST: $2.47 (-0.40%) • MKT CAP: $57.3M
market-cap
$57.3M
LAST: $1.88 (-3.09%) • MKT CAP: $59.1M
market-cap
$59.1M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BOLD VS. XBIT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BOLD | XBIT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 2/9 | +1.00 | BOLD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.5 | 33.8 | +12.75 | BOLD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $57.3M | $59.1M | -$1.8M | XBIT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BOLD REV | XBIT REV | BOLD GROSS % | XBIT GROSS % | BOLD FCF | XBIT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$47.2M | -$40.2M |
| FY 2024 | $0 | $0 | — | — | -$63.4M | -$32.3M |
| FY 2023 | $0 | $0 | — | — | -$46.9M | -$18.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BOLD // BETA —
XBIT // BETA —